Price Chart

Profile

Calliditas Therapeutics AB is a commercial-stage biopharma company focused on identifying, developing, and commercializing novel treatments in orphan indications, initially focusing on renal and hepatic diseases with unmet medical needs. The company's pipeline candidate is TARPEYO medication to reduce proteinuria in IgA nephropathy.
URL https://www.calliditas.se
Investor Relations URL https://www.calliditas.se/en/investors/
HQ State/Province N/A
Sector Health Care
Industry Pharmaceuticals
Equity Style Small Cap/Growth
Next Earnings Release N/A
Last Earnings Release Nov. 11, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Calliditas Therapeutics AB is a commercial-stage biopharma company focused on identifying, developing, and commercializing novel treatments in orphan indications, initially focusing on renal and hepatic diseases with unmet medical needs. The company's pipeline candidate is TARPEYO medication to reduce proteinuria in IgA nephropathy.
URL https://www.calliditas.se
Investor Relations URL https://www.calliditas.se/en/investors/
HQ State/Province N/A
Sector Health Care
Industry Pharmaceuticals
Equity Style Small Cap/Growth
Next Earnings Release N/A
Last Earnings Release Nov. 11, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A